Tryvio

 

                                        Disease Burden When Hypertension Is Uncontrolled

First New Class Of Hypertension In 4 Decades

Tryvio (Aprocitentan)

FDA Approved 

March 20, 20224

Mechanism Of Action 

Dual Endothelin Receptor Antagonist

Targeting  A New Pathway In Hypertension

Uses Of Targeting  A New Pathway

Theory To Practice

Current Events

World Creativity And Innovation Day 

New Drugs Can Prolong Life 

Targeting  A New Pathway

Snapshot

First New Drug In 40 Years For Hypertension

TAKES THE PRESSURE DOWN